📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-08-11 21:51
333 analysed today
FollowTelegram
333
Today
150,772
All-time analysed
43,178
Positive
6,703
Negative
92,118
Neutral
8,705
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
4 announcements match the current filters (relevance ≥ 5).
₹25 Cr Authorized Capital Increase and 2.58% ESOP Plan Approved by Shanmuga Hospital
Shanmuga Hospital's board has approved a significant 78.5% increase in authorized share capital from ₹14 crore to ₹25 crore, signaling potential future fundraising or corporate actions. The company is also introducing the 'SHL ESOP-2026' scheme, covering 3,50,000 shares (2.58% of equity) to incentivize employees. Strategically, the company is diversifying its business by amending its Memorandum of Association to include medical consultancy and software development. Additionally, a Power Purchase Agreement was signed at a tariff of ₹6.10 per unit to optimize operational costs.
Confidence: HIGH
What changedThe company has expanded its legal business scope to include consultancy and tech, increased its capital ceiling, and established a new employee stock option framework.
Why it mattersThe increase in authorized capital provides the headroom for future equity-based funding or bonus issues, while diversification into consultancy and software could introduce higher-margin service revenue alongside traditional hospital operations.
New Authorized Capital: ₹25,00,00,000ESOP Shares as % of Capital: 2.58%PPA Electricity Tariff: ₹6.10 per unitTTM Revenue: ₹95 CrPromoter Holding: 72.06%
📅 Short termThe market is likely to view the expansion of authorized capital and the introduction of ESOPs as growth-oriented signals, though actual impact depends on the execution of new business lines.
📈 Long termStructural shift from a pure-play hospital to a healthcare services and technology provider could re-rate the business if the consultancy and software verticals scale effectively.
⚠ Risk flags
- Equity dilution of 2.58% from the new ESOP plan
- Execution risk in diversifying into unrelated software development business
Key Highlights
Authorized share capital increased from ₹14,00,00,000 to ₹25,00,00,000 to support future growth.
New ESOP-2026 plan approved for 3,50,000 equity shares, representing 2.58% of total paid-up capital.
Power Purchase Agreement (PPA) signed with LNGS Private Limited at a tariff of ₹6.10 per unit.
Proposed diversification into medical education consultancy and digital/software application development.
Annual General Meeting (AGM) scheduled for September 18, 2026, with a record date of September 11, 2026.
👀 What to Watch
Investors should monitor the upcoming AGM on September 18, 2026, for shareholder approval of the capital increase and diversification plans, and watch for any subsequent fundraise announcements.
Shanmuga Hospital to increase Authorized Capital to ₹25 Cr and launches ESOP for 2.58% equity
Shanmuga Hospital's board has approved a 78.6% increase in authorized share capital from ₹14 Cr to ₹25 Cr, signaling potential future equity issuances. The company introduced the 'SHL ESOP-2026' plan covering 3,50,000 shares, which represents a 2.58% dilution of the current paid-up capital. Strategically, the company is diversifying its business objects to include medical consultancy and digital software solutions. It also entered a Power Purchase Agreement (PPA) with LNGS Private Limited at a tariff of ₹6.10 per unit to optimize energy costs.
Confidence: HIGH
What changedThe company has expanded its legal capacity to issue more shares and broadened its business scope to include medical education support and digital health applications.
Why it mattersThe increase in authorized capital is a preparatory step for future capital raises or corporate actions like bonus issues. Diversification into consultancy and software suggests a strategic shift toward higher-margin, asset-light revenue streams.
New Authorized Capital: ₹25,00,00,000ESOP Dilution: 2.58%PPA Tariff: ₹6.10 per unitAGM Date: 2026-09-18Record Date: 2026-09-11
📅 Short termThe market is likely to view the capital increase and diversification plans as growth-oriented, though ESOP dilution is a minor factor to note.
📈 Long termThe expansion into medical consultancy and digital solutions could structurally improve margins if executed well, diversifying the hospital's traditional revenue base.
⚠ Risk flags
- Equity dilution from ESOPs
- Execution risk in new business segments (software and consultancy)
- Discrepancy in PPA tariff mentioned in document (₹6.10 vs ₹6.50)
Key Highlights
Authorized share capital increased by ₹11 Cr to a new limit of ₹25 Cr
New ESOP 2026 plan covers 3,50,000 equity shares, representing 2.58% of paid-up capital
Power Purchase Agreement signed with LNGS Private Limited at a tariff of ₹6.10 per unit
Company to invest 1% in the paid-up capital of power supplier LNGS Private Limited
Main Object Clause amended to include medical consultancy and software development services
👀 What to Watch
Monitor the upcoming Annual General Meeting on September 18, 2026, for shareholder approval of these measures and watch for any subsequent announcements regarding specific fund-raising plans.
Shanmuga Hospital Approves ESOP (2.58% Capital), PPA at ₹6.10/unit, and Capital Hike to ₹25 Cr
Shanmuga Hospital's board has approved a series of structural changes, including a new ESOP plan for 3,50,000 shares (2.58% of capital) and a Power Purchase Agreement (PPA) with LNGS Private Limited at ₹6.10 per unit. The company is seeking to increase its authorized share capital by 78.5%, from ₹14 crore to ₹25 crore, signaling potential future fundraising or corporate actions. Additionally, the board proposed diversifying into medical consultancy and digital healthcare software development. While Q1 FY27 results were approved, the specific financial figures were not detailed in this summary extract.
Confidence: HIGH
What changedThe company is expanding its corporate framework to include employee stock incentives, a significantly higher authorized capital ceiling, and new business lines in healthcare consultancy and software.
Why it mattersThe increase in authorized capital provides the headroom for future equity-based fundraising. The diversification into software and consultancy suggests a strategic move toward asset-light healthcare services alongside traditional hospital operations.
ESOP Shares: 3,50,000 unitsESOP as % of Capital: 2.58%Authorized Capital Increase: 78.5% (to ₹25 Cr)PPA Tariff: ₹6.10 per unitInvestment in LNGS: 1% of paid-up capital
📅 Short termThe stock may see neutral to slightly positive sentiment as the market digests the expansion of business objects and the cost-saving PPA, though the lack of immediate Q1 figures in the brief limits reaction.
📈 Long termThe shift into digital solutions and consultancy could be margin-accretive if executed well, but represents a departure from core hospital management that requires monitoring.
⚠ Risk flags
- Equity dilution from ESOP (2.58%)
- Execution risk in new non-core business lines (software/consultancy)
- Investment in power provider (LNGS) adds minor non-core exposure
Key Highlights
Approved ESOP 2026 plan for 3,50,000 equity shares, representing 2.58% of total paid-up capital.
Proposed increase in Authorized Share Capital from ₹14 crore to ₹25 crore, subject to AGM approval.
Entered a PPA with LNGS Private Limited at a tariff of ₹6.10 per unit; includes a 1% equity investment in the power provider.
Proposed alteration of Main Object Clause to include medical consultancy and software/digital healthcare solutions.
6th Annual General Meeting (AGM) scheduled for September 18, 2026, with a record date of September 11, 2026.
👀 What to Watch
Investors should review the full Q1 FY27 financial statement once available and monitor the AGM on September 18 for approvals regarding the capital increase and diversification strategy.
Shanmuga Hospital to Increase Authorized Capital to ₹25 Cr and Launches 3.5L Share ESOP
Shanmuga Hospital's board has approved a significant 78.5% increase in authorized share capital from ₹14 Cr to ₹25 Cr, signaling potential future equity fundraising or corporate actions. The company is diversifying its business scope to include medical education consultancy and software development services. Additionally, a new ESOP scheme for 3,50,000 shares (2.58% of capital) and a Power Purchase Agreement at ₹6.10 per unit were cleared. These moves indicate a strategic shift toward broader healthcare services and operational cost management.
Confidence: HIGH
What changedThe company has expanded its legal capacity to issue equity and broadened its business objects to include non-hospital healthcare services and technology.
Why it mattersThe increase in authorized capital is a precursor to potential equity dilution or expansion funding. Diversifying into education and software suggests a move toward asset-light, higher-margin revenue streams beyond traditional patient care.
New Authorized Capital: ₹25,00,00,000ESOP Pool Size: 3,50,000 sharesESOP Dilution Potential: 2.58% of paid-up capitalPPA Tariff: ₹6.10 per unitInvestment in PPA Partner: 1% of paid-up capital
📅 Short termThe market may react positively to the growth signals and diversification, though the ESOP announcement introduces a small future dilution factor.
📈 Long termStructural significance depends on the successful execution of the new business lines (education and software) and how the company utilizes the expanded capital base.
⚠ Risk flags
- Equity dilution from the 2.58% ESOP pool
- Execution risk in diversifying into unrelated software and consultancy sectors
Key Highlights
Authorized share capital increased from ₹14 Cr to ₹25 Cr to support future growth plans.
Formulated 'SHL ESOP-2026' for 3,50,000 equity shares, representing 2.58% of total paid-up capital.
Entered a Power Purchase Agreement with LNGS Private Limited at a tariff of ₹6.10 per unit.
Proposed diversification into medical education consultancy and digital/software solutions for healthcare.
Fixed the 6th Annual General Meeting (AGM) for September 18, 2026, with a record date of September 11, 2026.
👀 What to Watch
Investors should monitor the upcoming AGM on September 18, 2026, for shareholder approval of the capital increase and diversification. Watch for any subsequent announcements regarding a fundraise or specific contracts in the new consultancy/software segments.
